Free Trial

Cresco Labs Inc. (OTCMKTS:CRLBF) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Cresco Labs logo with Medical background

Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) has earned an average rating of "Moderate Buy" from the eight ratings firms that are covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating, two have issued a buy rating and two have assigned a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $2.50.

A number of equities analysts have issued reports on CRLBF shares. Atb Cap Markets cut Cresco Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, December 9th. Cormark lowered Cresco Labs from a "moderate buy" rating to a "hold" rating in a research report on Monday, November 11th. Finally, Roth Capital raised Cresco Labs to a "strong-buy" rating in a research report on Sunday, November 10th.

Check Out Our Latest Stock Analysis on Cresco Labs

Cresco Labs Trading Up 6.4 %

Shares of OTCMKTS CRLBF traded up $0.06 during midday trading on Friday, reaching $0.99. 1,008,619 shares of the stock were exchanged, compared to its average volume of 541,196. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39. Cresco Labs has a 12 month low of $0.78 and a 12 month high of $2.65. The business has a 50-day simple moving average of $0.96 and a two-hundred day simple moving average of $1.36. The company has a market capitalization of $483.11 million, a price-to-earnings ratio of -4.95 and a beta of 1.79.

Cresco Labs Company Profile

(Get Free Report

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Further Reading

Analyst Recommendations for Cresco Labs (OTCMKTS:CRLBF)

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines